Small-Vessel Vasculitis Studies

If you are interested in any of our research studies, please contact our research group at 215-614-4417 or email us at rheumatologyresearch@uphs.upenn.edu.

Study Name

Medication Involved

Disease Studied

Currently Enrolling

Abatacept (CTLA4-Ig) for the Treatment of Relapsing, Non Severe, GPA (ABROGATE) YES GPA YES
The Assessment of Prednisone in Remission Trial (TAPIR) YES GPA YES
Benralizumab in eosinophilic granulomatosis with polyangiitis (EGPA) (MANDARA) YES EGPA YES
5506: The EGPA Registry NO EGPA YES
Nasal Microbiome in ANCA Associated Vasculitis and Relapsing Polychondritis (NMB) NO GPA, MPA, EGPA, & RP YES (EGPA & RP)
Low Dose Naltrexone to Improve Physical Health in Patients With Vasculitis (LoDoNaVasc) YES GPA, MPA, EGPA, GCA, Takayasu arteritis, PAN YES
One-Time DNA Study for Vasculitis (OTD) NO GPA, MPA, EGPA, GCA, Takayasu arteritis, PAN YES
Clinical Transcriptomics in Systemic Vasculitis (CUTIS) NO GPA, MPA, EGPA, PAN, IgAV, cryoglobulinemic, drug-induced, isolated cutaneous small vessel vasculitis, urticarial YES
Tissue Repository Collection Protocol NO GPA, MPA, EGPA, GCA, Takayasu's arteritis, PAN, cutaneous vasculitis YES
A Randomized Multicenter Study for Isolated Skin Vasculitis (ARAMIS) YES Cutaneous small/medium vessel vasculitis, cPAN, or IgA vasculitis YES